Jeremy Curnock-Cook

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Topigen Pharmaceuticals, Inc. develops drugs for respiratory diseases. The firm focuses on discovery and development of multiple pathway therapies for respiratory diseases with primary emphasis on asthma, chronic obstructive pulmonary disease, and allergic rhinitis. The company was founded by Paolo Renzi in 2000 and is headquartered in Montréal, Canada.

Part of Shell Plc, Shell Capital, Inc. is a company based in Houston, TX.

CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.

Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA.

EACOM Timber Corp. engages in the manufacture and distribution of lumber and wood-based products, and the management of forest resources. It offers stud grade lumber, dimension lumber, machine-stress rated lumber, specialty lumber and engineered woods. The company was founded by Hassan Salari on April 2, 1980 and is headquartered in Montreal, Canada.

The Institute of Cancer Research: Royal Cancer Hospital operates as a cancer research institution. The company was founded in 1909 and is headquartered in London, the United Kingdom.

Biocompatibles International Ltd. is a leading medical technology company in the field of drug device combination products with an Oncology products division and a Licensing division. In oncology, it has Bead products and BrachySciences and in Licensing, it has two components, CellMed and PC Licensing. It's products that will improve patient outcomes in the treatment of cardiovascular disease, cancer and benign tumours. Biocompatibles International was founded by Dennis Chapman in 1984 and is headquartered in Farnham, UK.

Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland.

CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia.

Precision Cellular Storage QSTP LLC provides stem cells samples collection and storage. The company was founded in 2009 and is headquartered in Doha, Qatar.

Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia.

Rothschild & Co. Asset Management US, Inc. (R&Co) is an asset management firm headquartered in Stamford, Connecticut. The firm was founded in 1962 and formerly known as Rothschild Asset Management, Inc. They are a wholly-owned subsidiary of Great Lakes Advisors LLC, ultimately owned by Wintrust Financial Corp. (NASDAQ: WTFC). R&Co provides bespoke investment solutions and advisory services to institutional clients, financial intermediaries, and third-party distributors.

Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand.

Avita Medical Ltd. engages in the development and distribution of regenerative and respiratory medicine and treatments. It operates through the following segments: Asia Pacific, Europe, and Americas. The Asia Pacific, Europe, and Americas segments involve in the sale of RECELL Devices. The company is headquartered in Valencia, CA.

Excalibur Fund Managers Ltd (Excalibur) is a venture capital firm founded in 1996 by Christopher Evans. The firm is headquartered in London, United Kingdom.

Union MedTech Plc is engaged in employing a buy and build strategy in the medical device arena. It is seeking to acquire and aggregate a number of proprietary medical device technologies in the areas, like orthopaedic and cardiac devices, as well as in novel areas such as bringing together complementary drug and device technologies. The company is focused on aggregating complementary technologies and adding significant value through clinical advancement, operational synergies and experienced management. The company was founded on November 13, 2007 and is headquartered in London, the United Kingdom.

Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.

Cantab Pharmaceuticals plc, based in Cambridge, England, was established in 1989 to exploit advances in immunology. Since that time, Cantab has become a leader in the areas of immunotherapy and gene delivery and has developed a broad portfolio of novel products for the treatment and prevention of many chronic infectious diseases, cancer and substance addiction.

Excalibur Group Holdings Ltd. is a private company based in London, UK. and has subsidiaries in the United Kingdom, the British Virgin Islands, Germany and Sweden. The British company was founded by Christopher Thomas Evans.

Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia.

AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.

Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany

SmartWard Pty Ltd. develops software for the healthcare industry. The company was founded by Lindsay Bevege in 2012 and is headquartered in Bruce, Australia.

BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.

Smart Matrix Ltd. engages in the research and development of medical solutions. It focuses on commercializing its propriety platform technology Smart Matrix, a medical device that acts as a scaffold to assist wound healing. The company was founded in 2011 and is headquartered in London, the United Kingdom.

Rex Bionics Pty Ltd. manufactures hands-free robotic devices for rehabilitation. The company was founded in 2014 and is headquartered in Melbourne, Australia.

Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia.

Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom.

Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA.

Avena Therapeutics Ltd. is a private company headquartered in Dublin, Ireland, that engages in research and experimental development on natural sciences and engineering.

Biocontrol Ltd. develops treatment to cure antibiotic resistant infections. The company was founded by David Harper on October 20, 1997 and is headquartered in Newbury, the United Kingdom.

Part of Gas Sensing Solutions Ltd., Cambridge Respiratory Innovations Ltd. develops and manufactures medical devices. The private company is based in Swavesey, UK.

Part of SeaDragon Ltd., Seadragon Marine Oils Ltd. is the largest refiner and blender of high-quality, internationally-certified Omega fish oils. The company is based in Nelson, New Zealand. The New Zealander company supplies nutraceutical and food manufacturers. Seadragon Marine Oils was acquired by SeaDragon Ltd. on October 15, 2012 for $15.48 million.

SeaDragon Ltd. engages in the manufacture of refined fish oils. It targets the production of Omega-3 bioactive compounds from three species: Tuna, Hoki, and marine-farmed Salmon. The company was founded on July 31, 1986 and is headquartered in Nelson, New Zealand.

Rex Bionics Plc engages in the development and manufacture of hands-free robotic exoskeletons designed to enable a wheelchair user to stand and walk. The company was founded by Richard Little and Robert Irving on November 13, 2007 and is headquartered in Marlow, the United Kingdom.

Vernalis Group, Inc. provides custom software and tech solutions.

Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy.

Virgin Health Bank Ltd. provides umbilical cord blood stem cell banking services. It offers family banking and community banking. The company was founded in 2009 and is headquartered in London, the United Kingdom.

Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada.